Search - tctmd.com

Displaying 581 - 600 of 609

Sort: Relevancy | Date

News Daily News

Baseline Anemia Raises Risk for Stent Thrombosis After DES

L.A. McKeown

April 04, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

March 06, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Daily News

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

L.A. McKeown

October 04, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

CT Perfusion Imaging Captures Anatomy, Function

Caitlin E. Cox

August 24, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Local-Regional Anesthesia Better Than General for EVAR

L.A. McKeown

July 22, 2011

Advertisement

Baseline Anemia Raises Risk for Stent Thrombosis After DES

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

Celecoxib Enhances DES Efficacy, But at Clinical Cost

TCTMD’s Top 10 Most Popular News Stories From 2011

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

CT Perfusion Imaging Captures Anatomy, Function

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Women Have Less Neointimal Hyperplasia Than Men With ZES

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Ticagrelor Gains FDA Approval for Use in ACS

Local-Regional Anesthesia Better Than General for EVAR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content